Skip To Main Content
Winston E. Abara on Muck Rack

Winston E. Abara

As seen in: Center for Disease Control and Prevention, The Lancet, Annals of Internal Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Winston E.

Contact Winston E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

|
By Winston E. Abara, Kyle T Bernstein, Julia Schillinger, Kristen Feemster
| The Lancet Verified
Summary Background Declining antimicrobial susceptibility to current gonorrhoea antibiotic treatment and inadequate treatment options have raised the possibility of untreatable gonorrhoea. New prevention approaches, such as vaccination, are needed. Outer membrane vesicle meningococcal serogroup B vaccines might be protective against gonorrhoea.
Open in Who Shared Issue with article?

Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses — United States, 2010–2017 | MMWR

|
By Winston E. Abara
| Center for Disease Control and Prevention
Winston E. Abara, MD1; Melissa G. Collier, MD1; Anne Moorman, MPH1; Danae Bixler, MD1; Jefferson Jones, MD2; Pallavi Annambhotla, PhD2; James Bowman, MD3; Marilyn E. Levi, MD3; John T. Brooks, MD4; Sridhar V. Basavaraju, MD2 (View author affiliations) View suggested citation Summary What is already known about this topic? Drug overdose deaths and hepatitis C virus (HCV) infections have increased with the U.S. opioid crisis.
Open in Who Shared Issue with article?

Hepatitis B Vaccination, Screening, and Linkage to Care

|
By Winston E. Abara, Amir Qaseem, Sarah Schillie, Brian McMahon
| Annals of Internal Medicine Verified
We agree with Dr. Lowe that passive transfer of hepatitis B surface antibodies or hepatitis B core antibodies after immunoglobulin therapy can confound the interpretation of serologic tests for HBV and should be considered when the results of the screening tests for this condition are being interpreted.
Open in Who Shared Issue with article?
See all 8 licensed articles (13 Total)